I. Metastatic castration-resistance prostate cancer (mCRPC) remains a major cause of cancer-related mortality despite advances in treatment over the past decade. Castration-resistant disease is cha...
No takes yet. Share an insight, caveat, or question.
Nypaver et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: